Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
66,399,673
-
Total 13F shares
-
28,187,960
-
Share change
-
+437,459
-
Total reported value
-
$620,070,946
-
Price per share
-
$22.00
-
Number of holders
-
81
-
Value change
-
+$8,597,860
-
Number of buys
-
49
-
Number of sells
-
26
Institutional Holders of RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) as of Q2 2019
As of 30 Jun 2019 RHYTHM PHARMACEUTICALS, INC. - COM (RYTM) had 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 28,187,960 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, TRV GP, LLC, BlackRock Inc., RA CAPITAL MANAGEMENT, LLC, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, and FEDERATED INVESTORS INC /PA/.
This table shows 81 institutional shareholders of the security as of 30 Jun 2019.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.